[EN] INHIBITORS OF BRUTON'S TYROSINE KINASE<br/>[FR] INHIBITEURS DE TYROSINE KINASE DE BRUTON
申请人:HOFFMANN LA ROCHE
公开号:WO2014135470A1
公开(公告)日:2014-09-12
This application discloses compounds according to generic Formula I: (I) wherein all variables are defined as described herein, which inhibit BTK. The compounds disclosed herein are useful to modulate the activity of BTK and treat diseases associated with excessive BTK activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions containing compounds of Formula I and at least one carrier, diluent or excipient.
本申请公开了根据通用式I的化合物:(I)其中所有变量的定义如本文所述,这些化合物抑制BTK。本文披露的化合物可用于调节BTK的活性并治疗与过度BTK活性相关的疾病。这些化合物还可用于治疗与异常B细胞增殖相关的炎症和自身免疫疾病,如类风湿性关节炎。还披露了含有通用式I化合物和至少一种载体、稀释剂或赋形剂的组合物。